Table 1 Patient assessment data for the 40 COVID-19 positive human subjects in the randomized control study of daily nasal and upper airway administration of calcium-rich salts (FEND) at Bangalore Baptist Hospital.
From: COVID-19 symptoms are reduced by targeted hydration of the nose, larynx and trachea
Participant No | Group | Age | Gender (M/F) | Blood Group | CRP | D dimer | Symptomatic | Fever? | Cough? | Difficulty Breathing? | Smell or Taste Difference? | Diarrhea or Vomit? | Body Pain? | Temp. (F) | Sp02 | Temp. (F) (2nd Reading) | Spo2 (2nd Reading) | Temp. (F) (3rd Reading) | Spo2 (3rd Reading) | Disease Severity Classification | Subjective Symptom Score Day 0 | Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | IV Antibiotic? | Steroid? | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Active | 30 | F | 6.4 | 271 | A | No | Yes | No | No | No | Yes | 98 | 96 | 98.2 | 96 | 98 | 98 | Mild | 3 | 2 | 2 | No | No | After 2 days, she was discharged as became better | ||||
2 | Active | 16 | F | 1.1 | 215 | S | Yes | Yes | No | Yes | No | Yes | 98.1 | 98 | 98.3 | 99 | 98.3 | 99 | Mild | 3 | 3 | 2 | 2 | 2 | No | Discharged | |||
3 | Control | 42 | M | O+ | 8.4 | 165 | S | Y | Y | N | N | N | Y | 100 | 96 | 98 | 97 | 98 | 98 | Mild | 3 | 3 | 2 | 2 | N | N | Discomfort in conutinuing nasal spray; Discharged | ||
4 | Control | 40 | M | O+ | 27.2 | 253 | S | N | Y | N | Y | N | N | 99 | 97 | 98.3 | 96 | 98 | 97 | Moderate | 4 | 4 | 3 | 3 | 3 | 2 | Y | Y | Discharged |
5 | Active | 23 | M | O+ | 2.8 | 218 | S | Y | N | N | Y | N | Y | 98.2 | 96 | 98.1 | 98 | 98.4 | 98 | Mild | 3 | 2 | 2 | 1 | 1 | N | Discharged | ||
6 | Active | 45 | M | A+ve | 6.4 | 250 | S | Y | Y | N | Y | Y | Y | 98 | 98 | 98.3 | 99 | 98 | 99 | Mild | 3 | 3 | 2 | 2 | N | N | Discharged | ||
7 | Active | 41 | M | A+ve | 31.3 | 304 | S | Y | Y | Y | Y | N | Y | 98.2 | 98 | 98 | 99 | 98 | 99 | Mild | 4 | 4 | 3 | 2 | 2 | Y | N | Discharged | |
8 | Control | 28 | F | O+ | 1.9 | 198 | S | Y | Y | N | N | N | Y | 98.3 | 99 | 98 | 98 | 98.4 | 99 | Mild | 3 | 3 | 2 | 2 | N | N | Discharged | ||
9 | Control | 39 | F | O+ | 25.4 | 290 | S | Y | Y | N | N | Y | Y | 98 | 98 | 98.2 | 98 | 98.1 | 98 | Mild | 3 | 3 | 2 | N | N | Discharged | |||
10 | Control | 28 | F | O+ | 2.3 | 197 | S | Y | Y | N | N | N | Y | 99 | 96 | 98 | 96 | 98 | 98 | Mild | 3 | 3 | 2 | N | N | Discharged | |||
11 | Control | 47 | M | A+ve | 23.1 | 218 | S | N | Y | N | Y | N | N | 98 | 97 | 98 | 96 | 98 | 98 | Mild | 3 | 3 | 3 | 3 | N | N | Discharged | ||
12 | Control | 41 | M | A+ve | 20.1 | 324 | A | N | Y | N | N | N | Y | 98.1 | 98 | 98.2 | 97 | 98.1 | 98 | Mild | 3 | 3 | 2 | N | N | Discharged | |||
13 | Active | 47 | M | 115.5 | 291 | S | Y | Y | Y | N | Y | Y | 98.1 | 97 | 97.8 | 96 | Moderate | 4 | 3 | 3 | Y | Y | escalated/klebsiella infection, Ctseverity 10/25 | ||||||
14 | Active | 32 | M | A+ve | 11.5 | 248 | S | Y | Y | N | N | Y | Y | 98 | 97 | 98 | 98 | 98.1 | 99 | Mild | 3 | 2 | 2 | N | N | Discharged | |||
15 | Active | 20 | M | O+ve | 17.7 | 324 | S | Y | Y | N | Y | N | Y | 98 | 96 | 98.3 | 98 | 98 | 98 | Mild | 2 | 2 | 2 | 1 | N | N | Discharged | ||
16 | Active | 42 | M | O+ve | 35.2 | 409 | S | N | Y | N | N | Y | N | 98.2 | 95 | 98 | 96 | 98.1 | 98 | Mild | 3 | 3 | 3 | 2 | 2 | 2 | Y | Y | Discharged |
17 | Active | 38 | M | O+ve | 28.8 | 229 | S | Y | Y | Y | N | N | Y | 98.1 | 97 | 98 | 93 | Moderate | 4 | 4 | 4 | Y | Y | escalated | |||||
18 | Control | 45 | F | O+ve | 7.9 | 244 | S | Y | Y | Y | N | N | Y | 98 | 96 | 98.1 | 96 | 98 | 96 | Mild | 3 | 3 | 2 | 2 | 2 | Y | N | escalated to increased d dimer | |
19 | Control | 53 | F | B+ve | 5.2 | 187 | S | Y | Y | N | N | Y | Y | 98 | 97 | 97.8 | 96 | 98.3 | 97 | Mild | 3 | 3 | 3 | 3 | 3 | 2 | Y | Y | steroids were given for 5 days |
20 | Control | 54 | F | – | 13 | 163 | S | Y | N | N | N | N | Y | 99 | 97 | 98 | 98 | 98 | 99 | Mild | 2 | 2 | 2 | 2 | Y | Y | Discharged | ||
21 | Control | 44 | F | O−ve | 13.6 | 208 | S | Y | Y | Y | N | Y | Y | 98.2 | 98 | 98.5 | 97 | 98.4 | 98 | Mild | 3 | 3 | 2 | 3 | 2 | Y | N | Diccharged -10/05/2021 | |
22 | Active | 37 | M | A+ | 3.2 | 201 | S | Y | N | N | Y | N | Y | 99 | 97 | 99 | 95 | 98 | 98 | Moderate | 3 | 3 | 3 | N | Y | Shifted to W-6 | |||
23 | Active | 45 | M | A+ | 214.5 | 357 | S | Y | Y | N | N | Y | Y | 98 | 97 | 98.8 | 95 | 98 | 93 | Moderate | 3 | 3 | Y | Y | Shited to ER on 8/05/2021 | ||||
24 | Active | 24 | M | O+ve | 6.4 | 179 | A | Y | Y | N | N | N | Y | 98 | 97 | 98.1 | 98 | Mild | 3 | 1 | 1 | N | N | Discharged | |||||
25 | Active | 41 | M | – | 49.7 | 187 | S | N | Y | Y | N | N | Y | 98 | 94 | 98.4 | 95 | 98.1 | 98 | Moderate | 2 | 2 | 1 | 1 | N | N | Discharged -8/05/2021 | ||
26 | Active | 29 | M | A+ve | 9 | 98 | S | N | N | N | N | Y | Y | 98.2 | 97 | 98.4 | 99 | 98.1 | 99 | mild | 3 | 3 | 3 | 2 | 2 | Y | N | Discharged -11/05/2021 | |
27 | Control | 53 | F | O+ve | 95.9 | 187 | S | Y | Y | N | Y | N | Y | 98 | 95 | 98.2 | 95 | 98.1 | 97 | moderate | 3 | 3 | 3 | 3 | 2 | Y | Y | Discharged | |
28 | Control | 57 | F | 2.8 | 290 | S | Y | Y | Y | Y | Y | Y | 98 | 96 | 97.9 | 98 | 98.3 | 96 | Mild | 3 | 3 | 2 | 2 | N | N | Discharged -10/05/2021 | |||
29 | Active | 55 | M | B+ve | 66.5 | 220 | S | Y | Y | N | Y | N | Y | 98 | 96 | 98.2 | 99 | Mild | 3 | 2 | 1 | N | Y (oral 1 dose) | Discharged -11/05/2021 | |||||
30 | Active | 33 | M | O−ve | 5.7 | 170 | S | Y | Y | Y | Y | Y | N | 98 | 97 | 98 | 99 | 98 | 99 | Mild | 3 | 2 | 2 | 1 | N | N | Discharged-14/05/2021 | ||
31 | Control | 33 | M | A+ve | 85.2 | 189 | S | Y | Y | Y | Y | Y | Y | 98 | 97 | 98.1 | 97 | 98.2 | 96 | Mild | 4 | 3 | 3 | 3 | N | Y | Discharged | ||
32 | Control | 50 | F | – | 12.52 | 204 | S | Y | Y | N | N | Y | Y | 98.5 | 96 | 98.4 | 98 | 98.1 | 97 | Mild | 3 | 2 | 2 | N | N | Discharged- | |||
33 | Control | 44 | F | – | 3.67 | 213 | S | Y | Y | N | N | Y | Y | 98 | 98 | 98.5 | 98 | 98 | 98 | Mild | 3 | 2 | 2 | N | N | Discharged | |||
34 | Control | 33 | F | A | Y | N | N | Y | Y | Y | Mild | 3 | 3 | 2 | N | Discharged 14/06/2021 | |||||||||||||
35 | Control | 48 | M | A+ve | 0.7 | 224 | S | Y | Y | N | N | N | Y | 98 | 99 | 98 | 98 | 98 | 99 | Mild | 3 | 3 | 3 | 2 | N | Discharged 17/06/2021 | |||
36 | Control | 30 | M | 0+ve | 31.1 | 234 | S | Y | Y | N | Y | N | N | 98 | 98 | 98.1 | 95 | 98 | 95 | Mild | 4 | 4 | 3 | 3 | Y | Discharged | |||
37 | Control | 29 | M | B+ve | 34.8 | 221 | S | N | Y | Y | Y | N | N | 100.1 | 95 | 97.1 | 95 | 97 | 94 | Mild | 4 | 4 | 2 | 2 | Y | Discharged 16/06/2021 | |||
38 | Active | 46 | M | A+ve | 45.4 | 324 | S | Y | Y | N | Y | N | Y | 98.6 | 96 | 101 | 98 | 97 | 98 | Mild | 4 | 4 | 2 | 2 | N | Discharged | |||
39 | Active | 29 | F | B+ve | 1.19 | 261 | S | Y | Y | Y | Y | Y | Y | 99.6 | 95 | 97.6 | 99 | 97 | 99 | Mild | 4 | 4 | 1 | 1 | N | Discharged | |||
40 | Active | 42 | M | A+ve | 23.7 | 403 | S | Y | Y | N | N | N | N | 100.1 | 97 | 98 | 98 | 97 | 98 | Mild | 3 | 3 | 1 | 1 | N | Discharged |
